Elizabeth J D'Amico1, Anthony Rodriguez2, Joan S Tucker2, Eric R Pedersen2, Regina A Shih3. 1. RAND Corporation, 1776 Main St., Santa Monica, CA 90401, USA. Electronic address: damico@rand.org. 2. RAND Corporation, 1776 Main St., Santa Monica, CA 90401, USA. 3. RAND Corporation, 1200 S Hayes St, Arlington, VA 22202, USA.
Abstract
BACKGROUND: Marijuana use during adolescence is associated with neurocognitive deficits and poorer functioning across several domains. It is likely that more states will pass both medical and recreational marijuana legalization laws in the coming elections; therefore, we must begin to look more closely at the longitudinal effects of medical marijuana (MM) advertising on marijuana use among adolescents so that we can better understand effects that this advertising may have on their subsequent marijuana use and related outcomes. METHODS: We followed two cohorts of 7th and 8th graders (mean age 13) recruited from school districts in Southern California from 2010 until 2017 (mean age 19) to examine effects of MM advertising on adolescents' marijuana use, cognitions, and consequences over seven years. Latent growth models examined trajectories of self-reported exposure to medical marijuana ads in the past three months and trajectories of use, cognitions, and consequences. RESULTS: Higher average exposure to MM advertising was associated with higher average use, intentions to use, positive expectancies, and negative consequences. Similarly, higher rates of change in MM advertising exposure were associated with higher rates of change in use, intentions, expectancies, and consequences over seven years. CONCLUSIONS: Results suggest that exposure to MM advertising may not only play a significant role in shaping attitudes about marijuana, but may also contribute to increased marijuana use and related negative consequences throughout adolescence. This highlights the importance of considering regulations for marijuana advertising, similar to regulations in place for the promotion of tobacco and alcohol in the U.S.
BACKGROUND:Marijuana use during adolescence is associated with neurocognitive deficits and poorer functioning across several domains. It is likely that more states will pass both medical and recreational marijuana legalization laws in the coming elections; therefore, we must begin to look more closely at the longitudinal effects of medical marijuana (MM) advertising on marijuana use among adolescents so that we can better understand effects that this advertising may have on their subsequent marijuana use and related outcomes. METHODS: We followed two cohorts of 7th and 8th graders (mean age 13) recruited from school districts in Southern California from 2010 until 2017 (mean age 19) to examine effects of MM advertising on adolescents' marijuana use, cognitions, and consequences over seven years. Latent growth models examined trajectories of self-reported exposure to medical marijuana ads in the past three months and trajectories of use, cognitions, and consequences. RESULTS: Higher average exposure to MM advertising was associated with higher average use, intentions to use, positive expectancies, and negative consequences. Similarly, higher rates of change in MM advertising exposure were associated with higher rates of change in use, intentions, expectancies, and consequences over seven years. CONCLUSIONS: Results suggest that exposure to MM advertising may not only play a significant role in shaping attitudes about marijuana, but may also contribute to increased marijuana use and related negative consequences throughout adolescence. This highlights the importance of considering regulations for marijuana advertising, similar to regulations in place for the promotion of tobacco and alcohol in the U.S.
Authors: Elizabeth J D'Amico; Jon M Houck; Sarah B Hunter; Jeremy N V Miles; Karen Chan Osilla; Brett A Ewing Journal: J Consult Clin Psychol Date: 2014-11-03
Authors: Rosalie Liccardo Pacula; Beau Kilmer; Alexander C Wagenaar; Frank J Chaloupka; Jonathan P Caulkins Journal: Am J Public Health Date: 2014-04-17 Impact factor: 9.308
Authors: Esther K Choo; Madeline Benz; Nikolas Zaller; Otis Warren; Kristin L Rising; K John McConnell Journal: J Adolesc Health Date: 2014-04-16 Impact factor: 5.012
Authors: Patricia A Cavazos-Rehg; Melissa Krauss; Sherri L Fisher; Patricia Salyer; Richard A Grucza; Laura Jean Bierut Journal: J Adolesc Health Date: 2015-02 Impact factor: 5.012
Authors: Jacqueline M Smith; Joel Mader; Andrew C H Szeto; Amelia M Arria; Ken C Winters; T Chris R Wilkes Journal: Can J Psychiatry Date: 2019-01-02 Impact factor: 4.356
Authors: Jennifer M Whitehill; Pamela J Trangenstein; Marina C Jenkins; David H Jernigan; Megan A Moreno Journal: J Adolesc Health Date: 2019-11-08 Impact factor: 5.012
Authors: Eric R Pedersen; Caislin L Firth; Anthony Rodriguez; Regina A Shih; Rachana Seelam; Lisa Kraus; Michael S Dunbar; Joan S Tucker; Beau Kilmer; Elizabeth J D'Amico Journal: Am J Addict Date: 2020-12-30
Authors: Elizabeth J D'Amico; Anthony Rodriguez; Michael S Dunbar; Caislin L Firth; Joan S Tucker; Rachana Seelam; Eric R Pedersen; Jordan P Davis Journal: Int J Drug Policy Date: 2020-10-07
Authors: Joan S Tucker; Anthony Rodriguez; Michael S Dunbar; Eric R Pedersen; Jordan P Davis; Regina A Shih; Elizabeth J D'Amico Journal: Drug Alcohol Depend Date: 2019-08-24 Impact factor: 4.492
Authors: Jordan P Davis; Eric R Pedersen; Joan S Tucker; Michael S Dunbar; Rachana Seelam; Regina Shih; Elizabeth J D'Amico Journal: J Youth Adolesc Date: 2019-04-25
Authors: Joan S Tucker; Anthony Rodriguez; Eric R Pedersen; Rachana Seelam; Regina A Shih; Elizabeth J D'Amico Journal: Drug Alcohol Depend Date: 2018-11-06 Impact factor: 4.492